Seegene HOME > Company > Investor relations > Financial statement
[1,000 won]
Items 2012 2011
1. Assets
Current Asset 52,618,562 62,888,056
Fixed Asset 30,997,087 15,599,739
Total of Asset 83,615,649 78,487,795
2. Liabilities & Capital
Current Liabilities 7,315,408 6,138,196
Fixed Liabilities 34,363,039 31,617,338
Total of Liabilities 41,678,447 37,755,534
Capital 6,548,050 6,536,300
Paid-in capital 15,872,685 23,306,871
Income Surplus 19,516,467 10,889,090
Total of Capital 41,937,202 40,732,261
Total of Liabilities & Capital 83,615,649 78,487,795


공시정보
Items 2012 2011
Sales 51,712,797 39,399,418
Cost of Goods Sold 16,610,753 12,487,665
Gross Profit 35,102,044 26,911,753
Selling and
Administrative Expenses
22,875,937 16,769,220
Operating Income 12,226,107 10,142,533
Non-operating Income 1,680,197 1,896,488
Non-operating Expenses 3,475,442 1,931,735
Earnings Before Taxes 10,430,863 10,107,286
Income Tax 1,327,924 756,469
Net Income 9,102,938 9,350,818



SEARCH
side 배너 씨젠소개부분
Simultaneous detection of 16 viruses using...
Obtained CE-IVD marking for Anyplex™ Flu...
Launched Anyplex™ TV/MH Real-time Detect...
Detection of T. vaginalis and M. hominis